RIVA-LABETALOL
Identification of Riva-Labetalol
| No description |
Google image searchProduct monograph
Active ingredient
labetalol hydrochloride, 200 MG
DIN: 02489414
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: LABORATOIRE RIVA INC.
Date: 04-SEP-2019
ATC:
- C07 — BETA BLOCKING AGENTS (ATC, ATC/DDD, )
- C07A — BETA BLOCKING AGENTS (ATC, ATC/DDD)
- C07AG — Alpha and beta blocking agents (ATC, ATC/DDD)
- C07AG01 — LABETALOL (ATC/DDD)
Reference brand drug: Trandate
Pharmaceutical standard: USP
